S

SMMT

Summit Therapeutics Inc

13.02

Jul 31 • 3:59 PM ET -0.42 (-3.12%)

13.20

Aftermarket • 7:54 PM ET +0.18 (1.38%)

Healthcare Biotechnology USA Large NASD

Peers: EXEL MRNA REGN VRTX BMRN INCY IONS ALNY GILD AMGN

| Held by: XBI VTI VB VXF VBR IBB IWP IWR IWF VHT

Scroll to Statements

Index	-
Market Cap	10.39B
Enterprise Value	9.72B
Income	-856.09M
Sales	0.00M
Book/sh	0.79
Cash/sh	0.87
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	265
IPO	Mar 05, 2015

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	16.39
P/C	15.03
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	6.96
Current Ratio	6.96
Debt/Eq	0.03
LT Debt/Eq	0.03
Option/Short	Yes / Yes

EPS (ttm)	-1.12
EPS next Y	-1.10
EPS next Q	-0.28
EPS this Y	21.79%
EPS next Y	1.90%
EPS next 5Y	26.42%
EPS past 3/5Y	-52.45% -13.76%
Sales past 3/5Y	- -
EPS Y/Y TTM	-11.10%
Sales Y/Y TTM	-
EPS Q/Q	63.61%
Sales Q/Q	-
Earnings	Jul 23 AMC
EPS/Sales Surpr.	-2.04% -

Insider Own	83.15%
Insider Trans	1.20%
Inst Own	15.07%
Inst Trans	0.80%
ROA	-159.09%
ROE	-192.50%
ROIC	-132.35%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-9.60%
SMA50	-11.86%
SMA200	-23.64%
Trades

Shs Outstand	793.12M
Shs Float	134.39M
Short Float	27.78%
Short Ratio	7.07
Short Interest	37.33M
52W High	30.98 -57.97%
52W Low	12.25 6.29%
Volatility	6.77% 5.89%
ATR (14)	0.89
RSI (14)	39.97
Beta	-1.23
Rel Volume	0.76
Avg Volume	5.28M
Volume	3,995,138

Perf Week	-4.69%
Perf Month	-9.46%
Perf Quarter	-39.33%
Perf Half Y	-15.45%
Perf YTD	-25.56%
Perf Year	-50.63%
Perf 3Y	520.00%
Perf 5Y	77.63%
Perf 10Y	86.00%
Recom	1.76
Target Price	29.06
Prev Close	13.44
Price	13.02
Change	-3.12%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)